Strides Shasun Gets USFDA Go-Ahead For Anti-Allergy Drug Business Business / Business 7 years ago 375 Views comments Citing IMS sales data, Strides Shasun said the US market for the approved product is approximately $17 million. Read more
Business Markets Closing: Buy Nifty with target of 9670; Maintain stop loss at 9590 Business / Business - 7 years ago
Business Gujarat RS: High drama delays vote count | कांग्रेस दो विधायकों के वोट रद्द करने पर अड़ी (News 360) Business / Business - 7 years ago
Business Big Story Big Debate : Why Karnataka needs separate flag? | एक देश में अलग झंडे क्यों? Business / Business - 7 years ago
Business IT and Pharma stocks show a positive incline, TCS disappointed at higher level Business / Business - 7 years ago
Business Joint venture between SAIL and ArcelorMittal finalised | SAIL - ArcelorMittal के बीच जॉइंट वेंचर Business / Business - 7 years ago
Business Superfast Futures Closing Special: Market shows pullback today Business / Business - 7 years ago
Comments